Clinical Trial Update: Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure [Phase 1]

View source ↗

Summary

Phase 1 trial of imatinib mesylate in patients with advanced cancer and kidney failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Malignant Neoplasm, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED